Skip to main navigation Skip to search Skip to main content

Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease

  • Genevera I. Allen
  • , Nicola Amoroso
  • , Catalina Anghel
  • , Venkat Balagurusamy
  • , Christopher J. Bare
  • , Derek Beaton
  • , Roberto Bellotti
  • , David A. Bennett
  • , Kevin L. Boehme
  • , Paul C. Boutros
  • , Laura Caberlotto
  • , Cristian Caloian
  • , Frederick Campbell
  • , Elias Chaibub Neto
  • , Yu Chuan Chang
  • , Beibei Chen
  • , Chien Yu Chen
  • , Ting Ying Chien
  • , Tim Clark
  • , Sudeshna Das
  • Christos Davatzikos, Jieyao Deng, Donna Dillenberger, Richard J.B. Dobson, Qilin Dong, Jimit Doshi, Denise Duma, Rosangela Errico, Guray Erus, Evan Everett, David W. Fardo, Stephen H. Friend, Holger Fröhlich, Jessica Gan, Peter St George-Hyslop, Satrajit S. Ghosh, Enrico Glaab, Robert C. Green, Yuanfang Guan, Ming Yi Hong, Chao Huang, Jinseub Hwang, Joseph Ibrahim, Paolo Inglese, Anandhi Iyappan, Qijia Jiang, Yuriko Katsumata, John S.K. Kauwe, Arno Klein, Dehan Kong, Roland Krause, Emilie Lalonde, Mario Lauria, Eunjee Lee, Xihui Lin, Zhandong Liu, Julie Livingstone, Benjamin A. Logsdon, Simon Lovestone, Tsung Wei Ma, Ashutosh Malhotra, Lara M. Mangravite, Taylor J. Maxwell, Emily Merrill, John Nagorski, Aishwarya Namasivayam, Manjari Narayan, Mufassra Naz, Stephen J. Newhouse, Thea C. Norman, Ramil N. Nurtdinov, Yen Jen Oyang, Yudi Pawitan, Shengwen Peng, Mette A. Peters, Stephen R. Piccolo, Paurush Praveen, Corrado Priami, Veronica Y. Sabelnykova, Philipp Senger, Xia Shen, Andrew Simmons, Aristeidis Sotiras, Gustavo Stolovitzky, Sabina Tangaro, Andrea Tateo, Yi An Tung, Nicholas J. Tustison, Erdem Varol, George Vradenburg, Michael W. Weiner, Guanghua Xiao, Lei Xie, Yang Xie, Jia Xu, Hojin Yang, Xiaowei Zhan, Yunyun Zhou, Fan Zhu, Hongtu Zhu, Shanfeng Zhu

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Abstract

Identifying accurate biomarkers of cognitive decline is essential for advancing early diagnosis and prevention therapies in Alzheimer's disease. The Alzheimer's disease DREAM Challenge was designed as a computational crowdsourced project to benchmark the current state-of-The-art in predicting cognitive outcomes in Alzheimer's disease based on high dimensional, publicly available genetic and structural imaging data. This meta-analysis failed to identify a meaningful predictor developed from either data modality, suggesting that alternate approaches should be considered for prediction of cognitive performance.

Original languageEnglish
Pages (from-to)645-653
Number of pages9
JournalAlzheimer's and Dementia
Volume12
Issue number6
DOIs
StatePublished - Jun 1 2016

Bibliographical note

Publisher Copyright:
© 2016 The Authors.

Funding

This study was supported by the following individuals and organizations: Alan Evans (McGill University), Gaurav Pandey (MSSM), Gil Rabinovici (UCSF), Kaj Blennow (Göteborg University), Kristine Yaffe (UCSF), Maria Isaac (EMA), Nolan Nichols (University of Washington), Paul Thompson (UCLA), Reisa Sperling (Harvard), Scott Small (Columbia), Guy Eakin (BrightFocus Foundation), Maria Carillo (Alzheimer's Association), Neil Buckholz (NIA), Alzheimer's Research UK, European Medicines Agency, Global CEO Initiative on Alzheimer's Disease, Pfizer, Inc, Ray and Dagmar Dolby Family Fund, Rosenberg Alzheimer's Project, Sanofi S.A, and Takeda Pharmaceutical Company Ltd, USAgainstAlzheimer's.

FundersFunder number
Alzheimer's Association
Alzheimer’s Research United Kingdom
Takeda Pharmaceuticals U.S.A.
University of California, Los Angeles
Harvard Transdisciplinary Research in Energetics and Cancer Center, Harvard University
McGill University
Neil Buckholz
Göteborg University
Maria Carillo
BrightFocus Foundation
The George Washington University
Guy Eakin
European Medicines Agency
National Institute of Mental HealthR01MH086633
National Institute on AgingU01AG032984, R01AG042611, R01AG014971, U01AG046152, R01AG030146, K01AG030514, U01AG024904, P30AG010161, R01AG036836, R01AG017917, P30AG010129, K25AG043546, R01AG015819

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Azheimer's disease
    • Big data
    • Bioinformatics
    • Biomarkers
    • Cognitive decline
    • Crowdsource
    • Genetics
    • Imaging

    ASJC Scopus subject areas

    • Epidemiology
    • Health Policy
    • Developmental Neuroscience
    • Clinical Neurology
    • Geriatrics and Gerontology
    • Cellular and Molecular Neuroscience
    • Psychiatry and Mental health

    Fingerprint

    Dive into the research topics of 'Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease'. Together they form a unique fingerprint.

    Cite this